FdaApplication
ANDA 078606
Identifiers
- fda_app_no: ANDA078606
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI ONCOLOGY PLC |
| application_type | ANDA |
| approval_date | 2008-05-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MITOXANTRONE HYDROCHLORIDE | MITOXANTRONE HYDROCHLORIDE | EQ 30MG BASE/15ML (EQ 2MG BASE/ML) | INJECTABLE;INJECTION |
| MITOXANTRONE HYDROCHLORIDE | MITOXANTRONE HYDROCHLORIDE | EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) | INJECTABLE;INJECTION |
| MITOXANTRONE HYDROCHLORIDE | MITOXANTRONE HYDROCHLORIDE | EQ 20MG BASE/10ML (EQ 2MG BASE/ML) | INJECTABLE;INJECTION |
3 products